Ra Capital Management, L.P. - Insider Trading & Ownership

Entity
Company
Location
200 Berkeley Street, 18 Th Floor, Boston, MA
Summary
The estimated value of insider holdings of Ra Capital Management, L.P. is at least $2.17B dollars as of February 10, 2025. Ra Capital Management, L.P. is the Director, 10%+ Owner of Janux Therapeutics, Inc. and owns shares of Janux Therapeutics, Inc. (JANX) stock worth about $482M. Ra Capital Management, L.P. is the Director, 10%+ Owner of 89bio, Inc. and owns shares of 89bio, Inc. (ETNB) stock worth about $208M. Ra Capital Management, L.P. is the Director, 10%+ Owner of Aerovate Therapeutics, Inc. and owns shares of Aerovate Therapeutics, Inc. (AVTE) stock worth about $198M. Ra Capital Management, L.P. is the Director, 10%+ Owner of Tyra Biosciences, Inc. and owns shares of Tyra Biosciences, Inc. (TYRA) stock worth about $154M. Ra Capital Management, L.P. is the Former 10% Owner of iTeos Therapeutics, Inc. and owns shares of iTeos Therapeutics, Inc. (ITOS) stock worth about $137M. Ra Capital Management, L.P. is the Director, 10%+ Owner of Nkarta, Inc. and owns shares of Nkarta, Inc. (NKTX) stock worth about $131M. Ra Capital Management, L.P. is the Director, 10%+ Owner of Cytek Biosciences, Inc. and owns shares of Cytek Biosciences, Inc. (CTKB) stock worth about $127M. Ra Capital Management, L.P. is the Director, 10%+ Owner of PepGen Inc. and owns shares of PepGen Inc. (PEPG) stock worth about $97.7M. Ra Capital Management, L.P. is the Director, 10%+ Owner of ARS Pharmaceuticals, Inc. and owns shares of ARS Pharmaceuticals, Inc. (SPRY) stock worth about $97.5M. Ra Capital Management, L.P. is the 10%+ Owner of Fulcrum Therapeutics, Inc. and owns shares of Fulcrum Therapeutics, Inc. (FULC) stock worth about $79.4M. Ra Capital Management, L.P. is the 10%+ Owner of 4D Molecular Therapeutics, Inc. and owns shares of 4D Molecular Therapeutics, Inc. (FDMT) stock worth about $74.5M. Ra Capital Management, L.P. is the Director, 10%+ Owner of Acrivon Therapeutics, Inc. and owns shares of Acrivon Therapeutics, Inc. (ACRV) stock worth about $67.3M. Ra Capital Management, L.P. is the Director of Mineralys Therapeutics, Inc. and owns shares of Mineralys Therapeutics, Inc. (MLYS) stock worth about $47.7M. Ra Capital Management, L.P. is the 10%+ Owner of Kala Pharmaceuticals, Inc. and owns shares of KALA BIO, Inc. (KALA) stock worth about $47.4M. Ra Capital Management, L.P. is the Director, 10%+ Owner of Acumen Pharmaceuticals, Inc. and owns shares of Acumen Pharmaceuticals, Inc. (ABOS) stock worth about $45.3M. Ra Capital Management, L.P. is the Director of Cidara Therapeutics, Inc. and owns shares of Cidara Therapeutics, Inc. (CDTX) stock worth about $35.5M. Ra Capital Management, L.P. is the Director, 10%+ Owner of Vor Biopharma Inc. and owns shares of Vor Biopharma Inc. (VOR) stock worth about $32.5M. Ra Capital Management, L.P. is the Former 10% owner of Enliven Therapeutics, Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $32.1M. Ra Capital Management, L.P. is the Director, 10%+ Owner of Solid Biosciences Inc. and owns shares of Solid Biosciences Inc. (SLDB) stock worth about $23.2M. Ra Capital Management, L.P. is the Director of Therapeutics Acquisition Corp. and owns shares of POINT Biopharma Global Inc. stock worth about $13.7M. Ra Capital Management, L.P. is the Director, 10%+ Owner of LENZ Therapeutics, Inc. and owns shares of LENZ Therapeutics, Inc. (LENZ) stock worth about $13.5M. Ra Capital Management, L.P. is the Director, 10%+ Owner of Eliem Therapeutics, Inc. and owns shares of Climb Bio, Inc. (CLYM) stock worth about $11M. Ra Capital Management, L.P. is the 10%+ Owner of RxSight, Inc. and owns shares of RxSight, Inc. (RXST) stock worth about $10.3M. Ra Capital Management, L.P. is the Director of Black Diamond Therapeutics, Inc. and owns shares of Black Diamond Therapeutics, Inc. (BDTX) stock worth about $8.77M. Ra Capital Management, L.P. is the 10%+ Owner of AN2 Therapeutics, Inc. and owns shares of AN2 Therapeutics, Inc. (ANTX) stock worth about $325K. Ra Capital Management, L.P. is the Director, 10%+ Owner of Wave Life Sciences Ltd. and owns shares of Wave Life Sciences Ltd. (WVE) stock worth about $40K.
All Insider Reports
All Insider Reports

Ownership of Ra Capital Management, L.P.

Insider Transactions Reported by Ra Capital Management, L.P.:

* An asterisk sign (*) next to the price indicates that the price is likely invalid.